KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $464.0 million.

  • Elevance Health's Cash from Investing Activities rose 12832.72% to $464.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.3 billion, marking a year-over-year increase of 7398.88%. This contributed to the annual value of -$1.3 billion for FY2025, which is 7398.88% up from last year.
  • According to the latest figures from Q4 2025, Elevance Health's Cash from Investing Activities is $464.0 million, which was up 12832.72% from -$1.2 billion recorded in Q3 2025.
  • Elevance Health's Cash from Investing Activities' 5-year high stood at $464.0 million during Q4 2025, with a 5-year trough of -$4.9 billion in Q2 2021.
  • For the 5-year period, Elevance Health's Cash from Investing Activities averaged around -$1.3 billion, with its median value being -$1.1 billion (2023).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first tumbled by 171797.75% in 2021, then skyrocketed by 12991.72% in 2022.
  • Over the past 5 years, Elevance Health's Cash from Investing Activities (Quarter) stood at -$966.0 million in 2021, then skyrocketed by 129.92% to $289.0 million in 2022, then crashed by 456.06% to -$1.0 billion in 2023, then tumbled by 59.18% to -$1.6 billion in 2024, then skyrocketed by 128.33% to $464.0 million in 2025.
  • Its Cash from Investing Activities stands at $464.0 million for Q4 2025, versus -$1.2 billion for Q3 2025 and -$687.0 million for Q2 2025.